Targeting Persistent Human Papillomavirus Infection
While the majority of Human papillomavirus (HPV) infections are transient and cleared within a couple of years following exposure, 10–20% of infections persist latently, leading to disease progression and, ultimately, various forms of invasive cancer. Despite the clinical efficiency of recently deve...
Main Authors: | Srinidhi Shanmugasundaram, Jianxin You |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2017-08-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/9/8/229 |
Similar Items
-
EPIDEMIOLOGICAL, SOCIAL AND ECONOMIC EVIDENCES OF VACCINATION AGAINST HUMAN PAPILLOMAVIRUS INFECTION IN SAINT-PETERSBURG
by: L. V. Lyalina
Published: (2014-07-01) -
Human Papillomavirus and Cervical Cancer
by: Elizabeth R. Unger, et al.
Published: (2004-11-01) -
Persistent Human Papillomavirus Infection
by: Ashley N. Della Fera, et al.
Published: (2021-02-01) -
Human papillomavirus type 16 E6 variants in France and risk of viral persistence
by: Cornet Iris, et al.
Published: (2013-01-01) -
Persistence of cervical high-risk human papillomavirus in women living with HIV in Denmark – the SHADE
by: Kristina Thorsteinsson, et al.
Published: (2019-08-01)